Advertisements

Bisoprolol VP

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Bisoprolol VP

Property Description
Active Ingredient Bisoprolol Fumarate
Form Oral tablet
Pharmacological Class Selective Beta-blocker (beta1-adrenoceptor antagonist)
General Purpose Reduction of cardiac workload and stabilization of heart rhythm
Origin Synthetic compound

What Type of Medicine is Bisoprolol VP?

Bisoprolol VP is a pharmaceutical preparation containing the active chemical entity Bisoprolol Fumarate, which is medically classified as a selective beta-blocker (beta1-adrenoceptor antagonist). This medicine is clinically recognized for its targeted action within the cardiovascular system. The preparation is intended for oral administration, typically formulated as a compressed solid tablet.

The classification as a selective beta-blocker means that Bisoprolol primarily targets and temporarily inhibits the beta1 adrenergic receptors, which are found predominantly within heart tissue. This targeted action is an essential feature, ensuring the compound's primary effects are focused on the cardiac system and is a factor often considered when managing cardiovascular regimens.

Bisoprolol Fumarate: Synthetic Compound and Single-Agent Formulation

The therapeutic efficacy of Bisoprolol VP relies entirely on the Bisoprolol Fumarate component, a synthetic organic compound produced through defined chemical processes. The final preparation is a single-agent product, meaning the oral tablet contains only Bisoprolol as the principal therapeutic substance. As a solid oral pharmaceutical preparation, the tablets are composed of the active substance combined with pharmacologically inert materials (excipients), which ensure the precise and consistent delivery of the active ingredient.

What is the General Purpose of a Selective Beta-Blocker?

The general purpose of a selective beta-blocker is to exert a modulating effect on the heart's activity by reducing its response to the body's natural stress hormones. This action serves to decrease the overall mechanical workload on the heart and contributes to the stabilization of the heart's rhythm. This foundational physiological action allows the heart to beat more slowly, regularly, and with less strain, which is the primary objective of this specific type of cardiovascular therapeutic agent.

Advertisements

What side effects are possible with Bisoprolol VP?

Possible Side Effects and Safety Information

The safety profile of Bisoprolol VP is derived from its pharmacological action as a beta-blocker. Officially documented adverse reactions primarily involve the cardiovascular, nervous, and gastrointestinal systems.

Adverse Reaction Frequency

Classification Examples of Adverse Reactions (System-Organ Class)
Very Common (ge 1/10) Bradycardia (in heart failure treatment)
Common (ge 1/100 to < 1/10) Fatigue, dizziness, headache, nausea, diarrhea, cold/numb extremities
Uncommon (ge 1/1,000 to < 1/100) Hypotension, heart rhythm disturbances, muscle cramps, depression
Rare (ge 1/10,000 to < 1/1,000) Nightmares, hallucinations, syncope, hepatitis, hypersensitivity reactions, reduced tear flow

Clinically Significant Safety Considerations

Serious Adverse Reactions documented in regulatory sources include the exacerbation of pre-existing heart failure, profound bradycardia, and hypotension. Bronchospasm may also occur, especially in patients with existing obstructive airway disease. Bisoprolol is contraindicated in conditions such as acute heart failure, cardiogenic shock, second or third-degree atrioventricular (AV) block, and symptomatic bradycardia.

Safety Restrictions: The drug must not be stopped abruptly. Abrupt cessation, particularly in patients with coronary artery disease, carries a significant risk of worsening angina pectoris, myocardial infarction, or ventricular arrhythmia. The dosage must be tapered gradually under medical supervision. Caution is required in patients with diabetes (as it may mask signs of hypoglycemia), severe renal or hepatic impairment, and Prinzmetal's angina. Safety and efficacy are not established in the pediatric population (under 18 years).

Advertisements

Overdose and Emergency Response

The official regulatory profile for Bisoprolol VP overdose details expected manifestations linked to its profound physiological effects. Documented overdose presentations include bradycardia (abnormally slow heart rate) and significant hypotension (low blood pressure). Regulatory documents also list the potential for worsening congestive heart failure and acute bronchospasm. A critical metabolic manifestation is hypoglycemia (low blood sugar), which is explicitly noted as a concern in children following exposure.

The severity classification includes the potential for severe and life-threatening outcomes such as advanced heart block and profound hypotension.

Regulatory guidance mandates that patients seek immediate medical attention or contact emergency services immediately for any suspected overdose, especially if severe signs like breathing difficulty or loss of consciousness are present. Management focuses strictly on symptomatic and supportive treatment; no specific antidote is known. Protocols describe interventions such as the use of Glucagon or Atropine to manage severe bradycardia and hypotension. Treatment decisions are constrained by the limited dialyzability of Bisoprolol Fumarate. The overall profile reinforces that immediate emergency care is required to address the potential for severe cardiovascular compromise.

Advertisements

Therapeutic Uses of Bisoprolol VP

What Bisoprolol VP Treats: Main Uses and Benefits

Bisoprolol VP is commonly used to address several conditions involving symptoms related to heightened physiological activity and chronic cardiovascular strain. It is applicable within clinical settings that involve acute or disruptive symptom patterns related to cardiovascular functional stress.

This medication is typically used for managing hypertension (high blood pressure), providing supportive relief for Chronic Stable Angina Pectoris (chest pain), and assists with maintaining functional stability in the context of Chronic Heart Failure in clinically stable patients. It may also be part of the management plan for specific irregular heart rhythms, as it is relevant for easing symptoms related to heightened physiological activity.

“It assists with maintaining functional stability and supports patients during episodes of heightened discomfort by easing the overall symptom load.”

Used in conditions marked by increased physiological stress, Bisoprolol VP is relevant for managing symptom clusters that may become disruptive or create noticeable physiological strain. It contributes to improved day-to-day comfort during symptomatic periods and assists with maintaining functional stability.

Quick Fact: Support for Symptoms of Cardiac Strain
This medicine is commonly used to help with reducing the frequency and intensity of stable chest pain episodes (angina), assisting in the management of symptoms linked to organ-specific functional stress.
Advertisements

Eligibility and Restrictions for Use

Bisoprolol VP is generally prescribed for adults to manage conditions such as high blood pressure (hypertension) and stable chronic heart failure. However, it is not suitable for everyone, and a healthcare professional must assess individual patient history before initiation.

Contraindications (Who Should Not Use Bisoprolol VP)

Bisoprolol VP is contraindicated and should not be used in people with certain pre-existing medical conditions. These include:

  • Severe or worsening heart failure
  • Cardiogenic shock (a severe form of heart failure where the heart cannot pump enough blood)
  • Severe bradycardia (very slow heart rate)
  • Second- or third-degree atrioventricular (AV) block (a serious heart rhythm disorder)
  • Sick sinus syndrome (unless a pacemaker is in place)
  • Severe asthma or severe chronic obstructive pulmonary disease (COPD)
  • Metabolic acidosis (too much acid in the blood)
  • Severe peripheral arterial occlusive disease or Raynaud's phenomenon
  • Known allergy to bisoprolol or any of the tablets' ingredients
Special Considerations (Consult Doctor First)
* Diabetes (may mask symptoms of low blood sugar)
* Hyperthyroidism (may mask symptoms of an overactive thyroid)
* Psoriasis (can worsen condition)
* Kidney or liver impairment (dose adjustment may be needed)
* Pregnancy or breastfeeding
* Prinzmetal's angina (a type of chest pain)

Note: Abrupt discontinuation of Bisoprolol VP can lead to serious heart problems, especially in patients with ischemic heart disease. The dose must be gradually reduced under medical supervision.

Advertisements

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

This information on Bisoprolol VP (Bisoprolol Fumarate) interactions is based solely on official government regulatory documents, outlining officially documented combination risks and requirements.


Official Combination Restrictions

Regulatory agencies identify certain substances where concurrent use is either contraindicated or not recommended due to the potential for excessive additive effects:

Classification Interacting Substances (Examples)
Contraindicated Calcium antagonists of the Verapamil type; Other beta-blocking agents; Fingolimod
Not Recommended Calcium antagonists of the Diltiazem type; Certain Antiarrhythmic agents (e.g., Disopyramide)

Documented Pharmacokinetic and Pharmacodynamic Interactions

Interactions are defined by effects on drug clearance or compounded physiological action. The official profile notes:

  • Pharmacokinetic Interference: The medicine Rifampin is documented to increase the metabolic clearance of Bisoprolol Fumarate, resulting in a shortened elimination half-life.
  • Pharmacodynamic Reinforcement: Co-administration with Digitalis glycosides or Centrally-acting antihypertensives (e.g., Clonidine) can lead to additive effects, further slowing heart rate or depressing AV conduction.

Procedural Constraint

For patients co-administering Bisoprolol VP with Clonidine, official prescribing information mandates that the beta-blocker must be discontinued several days before the withdrawal of Clonidine to mitigate the risk of adverse rebound effects.

Advertisements

Mechanism of Action

Selective Blockade of Cardiac Adrenergic Receptors

Bisoprolol Fumarate acts as a competitive antagonist, preferentially binding to beta1-adrenergic receptors (beta1-AR) on cardiac and renal cells. This action blocks the binding of stimulating catecholamines like Norepinephrine, initiating the suppression of the intracellular signaling cascade (reduction of cyclic AMP (cAMP) and calcium ion (Ca^2+) influx), which diminishes catecholamine-mediated cardiac excitation and contractility.

Modulation of Cardiac Functional Parameters and Electrical Signaling

The resulting suppression of the signaling cascade produces predictable physiological consequences: a negative chronotropic effect (slowing the heart rate) and a negative inotropic effect (reducing the force of contraction). These changes constitute a reduction in cardiac effort and myocardial oxygen consumption, contributing to the modulation of electrical signal propagation through the SA and AV nodes.

Influence on the Systemic Renin-Angiotensin Pathway

The mechanism extends beyond the heart to the beta1-AR on kidney cells, where their blockade reduces the release of the enzyme renin. By inhibiting the initial release of renin in the Renin-Angiotensin System (RAS), the mechanism produces a systemic effect influencing vascular tone, which contributes to the resultant systemic blood pressure reduction.

Advertisements

Dosage and Administration Information

How to Use Bisoprolol VP

Bisoprolol VP, containing Bisoprolol Fumarate, is intended solely for oral administration as a tablet. The medicine is typically taken once daily (qDay), generally in the morning, and may be swallowed with or without food.

Standard Labeled Dosing Regimens

Official dosing is tailored to the condition. The maximum recommended dose is 20 mg once daily for hypertension/angina and 10 mg once daily for heart failure.

Condition Initial Dose (Adults) Maintenance Dose (Adults) Max Dose (Adults)
Hypertension/Angina 5 mg once daily 10 mg once daily 20 mg once daily
Chronic Stable Heart Failure 1.25 mg once daily Up to 10 mg once daily 10 mg once daily

Official Titration and Discontinuation

For Chronic Stable Heart Failure, treatment involves a slow up-titration phase, where the dose is gradually doubled every one to two weeks, contingent on patient tolerability. This incremental approach ensures stability during the dose adjustment phase. If a dose is missed, it is generally taken as soon as remembered that day; otherwise, the missed dose is skipped and the next dose is resumed at the usual time.

Special Procedural Requirements

Therapy with Bisoprolol VP is generally considered long-term. Abrupt discontinuation is avoided. The dosage is reduced gradually, or tapered, over approximately one to two weeks. For patients with severe renal or hepatic impairment, the initial dose is generally lower (2.5 mg once daily), and the maximum daily dose is restricted to 10 mg.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence Overview

Bisoprolol VP, a cardioselective beta-1 adrenergic blocker, has been a focus of extensive clinical research, primarily in the management of cardiovascular conditions.

Evidence in Chronic Heart Failure

Research has explored the effects of bisoprolol in individuals with chronic heart failure (CHF), particularly those with a reduced left ventricular ejection fraction (HFrEF). Landmark clinical trials, such as the Cardiac Insufficiency Bisoprolol Study (CIBIS-II), reported that the addition of bisoprolol to standard therapy was associated with a reduction in all-cause mortality and hospitalizations in patients with stable, mild to moderate CHF.

Studies have consistently described that its mechanism of slowing the heart rate and reducing cardiac workload is linked to these observed long-term outcomes in the heart failure population. Continuing research supports its role as a key component of guideline-directed medical therapy for this condition.

Evidence in Hypertension and Safety Profile

In the treatment of hypertension (high blood pressure), clinical data indicates that bisoprolol is associated with a sustained lowering of both systolic and diastolic blood pressure, along with a decrease in heart rate. Studies have examined its effectiveness across various patient groups, including those with elevated heart rates at baseline.

Safety data collected from clinical trials describes that bisoprolol is generally well-tolerated. Common adverse events reported in trials include fatigue, dizziness, and slow heart rate (bradycardia). Due to its beta1-selectivity, studies have investigated whether it may offer a preferable profile for patients with certain respiratory conditions, compared to non-selective beta-blockers, though this must be individually assessed by a healthcare provider.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Bisoprolol VP (FAQ)


Q: How quickly does Bisoprolol VP start lowering my heart rate?

Official studies indicate that the maximum effect of Bisoprolol Fumarate on slowing a fast heart rate, such as that caused by exercise, typically occurs within 1 to 4 hours after taking the tablet. This time frame reflects the speed at which the medicine begins to work in the body.


Q: How long does the effect of one dose of Bisoprolol VP last?

According to official product information, the effects of Bisoprolol Fumarate on regulating heart rate generally last for 24 hours at standard doses. The medicine's official dosing is typically once daily, consistent with this duration. The time it takes for the drug level in the body to drop by half (plasma elimination half-life) is approximately 9 to 12 hours.


Q: Can Bisoprolol VP cause weight gain or loss?

Official safety data lists weight gain as a reported adverse reaction noted in postmarketing experience. Weight changes are best addressed by consulting a healthcare professional. Regulatory documents primarily note reports of weight gain.


Q: Is it safe to take ibuprofen (Advil) with Bisoprolol VP?

Authoritative sources, such as official drug information, suggest that non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen may reduce the effectiveness of Bisoprolol Fumarate in lowering blood pressure. It is important for patients to inform their healthcare provider about all medications, including over-the-counter NSAIDs.


Q: Does Bisoprolol VP interact with multivitamins or supplements?

Regulatory information indicates that taking Bisoprolol Fumarate together with a multivitamin that contains minerals may potentially reduce its desired effects. Official information may advise separating the administration of Bisoprolol Fumarate and multivitamins with minerals by at least 2 hours.


Q: Can Bisoprolol VP cause dizziness or lightheadedness?

Dizziness is listed as a commonly reported side effect in official documents. Lightheadedness is also reported and is often associated with low blood pressure (hypotension), which is another potential effect of the medication.


Q: Should Bisoprolol VP be taken in the morning or at night?

Official prescribing information generally recommends a once-daily regimen. Consistency in taking the medication at the same time each day is emphasized. The choice between morning or night use is best made in consultation with a healthcare provider.


Q: Does Bisoprolol VP affect sleep or cause insomnia?

Official adverse reaction data includes insomnia (difficulty sleeping) as an uncommon side effect of Bisoprolol Fumarate. Other rare central nervous system effects, such as nightmares and hallucinations, have also been reported.


Q: Does taking Bisoprolol VP affect exercise tolerance?

The mechanism of Bisoprolol Fumarate works by reducing the heart's workload and slowing the heart rate, particularly during stress or exercise. In clinical studies, this resulted in a reduction of exercise-induced fast heart rate (tachycardia).


Q: What is the typical time frame to see the full therapeutic benefit of Bisoprolol VP?

For the treatment of high blood pressure, clinical studies show that significant reductions are typically observed within one week of starting treatment. This effect generally remains stable and sustained with continued use of the medicine.


Q: Can Bisoprolol VP affect sexual function?

Official prescribing information includes disturbances in sexual potency as a rare adverse reaction. Any changes in sexual function should be addressed with a healthcare provider.


Q: Does alcohol change the way Bisoprolol VP works?

Official information warns that Bisoprolol Fumarate and alcohol can have additive effects in lowering blood pressure. This combination may increase the risk of experiencing low blood pressure symptoms, such as dizziness or fainting.


Q: Does Bisoprolol VP affect kidney function?

Bisoprolol Fumarate is eliminated from the body through both the liver and the kidney, with about 50% excreted unchanged in the urine. Official guidelines recommend dose adjustments for patients who have severe kidney impairment.


Q: Is Bisoprolol VP safe for people with diabetes?

Regulatory documents indicate that Bisoprolol Fumarate requires caution when used by individuals with diabetes. This is because it may hide or mask some symptoms of low blood sugar (hypoglycemia), such as a fast or pounding heartbeat.


Q: Why do some people experience cold hands and feet with Bisoprolol VP?

Official documentation lists cold or numb extremities as a common side effect. This is related to the drug’s action on circulation, which is why the side effect is noted in official documentation.


Q: Is Bisoprolol VP a blood thinner?

No, Bisoprolol Fumarate is a selective beta-blocker. Its primary action is to reduce the heart rate and affect blood vessels, and it is not classified as a 'blood thinner' (an anticoagulant or antiplatelet medicine).


Q: What kind of blood pressure drop should I expect from Bisoprolol VP?

In clinical trials for high blood pressure, the medicine was reported to cause average blood pressure reductions of approximately 10 to 13 mm Hg (systolic) and 8 to 12 mm Hg (diastolic) at the typical maintenance doses. Individual results may vary.


Q: Can Bisoprolol VP cause changes in mood or depression?

Regulatory safety data lists depression as an uncommon side effect. Additionally, other central nervous system effects such as nightmares and hallucinations are listed as rare adverse reactions.


Q: How is Bisoprolol VP eliminated from the body?

The medicine is eliminated from the body almost equally by the kidneys (renal pathway) and the liver (non-renal pathway). Approximately 50% of the active substance is excreted unchanged in the urine.


Q: Is it necessary to take Bisoprolol VP with food?

Official dosing instructions state that the medicine can be swallowed with or without food. Taking it at mealtime is a matter of patient preference and consistency, not a requirement for its effectiveness.


Q: Can Bisoprolol VP be crushed or split?

The official product labeling for Bisoprolol Fumarate often describes the tablets as scored, suggesting they may be split. Specific information regarding crushing tablets is not always provided in regulatory documents.


Q: Are there generic versions of Bisoprolol VP available?

Yes, regulatory agencies like the FDA have approved generic versions of Bisoprolol Fumarate tablets. These generic products are approved by regulatory agencies as being comparable to the brand-name medication.


Q: Why is careful monitoring needed when switching from another beta-blocker to Bisoprolol VP?

Official warnings state that abrupt cessation of any beta-blocker, especially in patients with existing heart disease, can lead to serious adverse effects. Dosage reduction or changes between beta-blockers typically require a gradual process under the care of a healthcare professional.


Q: Can people with low blood pressure still be prescribed Bisoprolol VP?

Official regulatory documents list symptomatic severe hypotension (very low blood pressure) and cardiogenic shock as contraindications (conditions where the drug must not be used). The determination of whether the medicine can be used in the presence of low blood pressure is based on a healthcare assessment.


Q: Does Bisoprolol VP treat the symptoms or the underlying cause of high blood pressure?

As a beta-blocker, Bisoprolol Fumarate is a treatment for the condition of hypertension. It works by modulating the body's response to stress hormones to reduce the heart rate and blood pressure, rather than eliminating the root cause of the hypertension.


Q: Are there differences in how Bisoprolol VP works for different age groups?

Official data indicates that the drug's half-life is slightly longer in elderly patients compared to younger adults, likely due to changes in kidney function. Also, safety and effectiveness have not been established for children under 18 years of age.


Q: Why is Bisoprolol VP sometimes given with diuretics ('water pills')?

Clinical studies have shown that Bisoprolol Fumarate is an effective blood pressure medication when used in combination with thiazide diuretics. The combination provides an additive effect in helping to achieve lower blood pressure.


Q: Does Bisoprolol VP interact with any common pain relievers?

Yes, official sources generally warn that common pain relievers classified as non-steroidal anti-inflammatory drugs (NSAIDs) can reduce the blood pressure-lowering effect of Bisoprolol Fumarate.

Advertisements

How should Bisoprolol VP be stored and disposed of?

Official Storage and Disposal Requirements

Bisoprolol fumarate tablets must be stored according to regulatory requirements to ensure stability. Official labeling mandates storage at room temperature (20 C to 25 C) or below 25 C or 30 C, depending on the jurisdiction. The medicine must be protected from moisture and direct light and kept from freezing or excessive heat.

Tablets should be kept in the original container and containers must be tightly closed. Storage must include child-safety measures, such as keeping the product out of the sight and reach of children.

Disposal of unused or expired product must be done in accordance with local requirements, often involving disposal at an approved waste disposal plant.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bisoprolol VP found in:

A-Z Index: